These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6609640)
1. Cholestatic hepatitis from erythromycin ethylsuccinate. Report of two cases. Diehl AM; Latham P; Boitnott JK; Mann J; Maddrey WC Am J Med; 1984 May; 76(5):931-4. PubMed ID: 6609640 [TBL] [Abstract][Full Text] [Related]
2. Prolonged cholestasis and disappearance of interlobular bile ducts following chlorpropamide and erythromycin ethylsuccinate. Case of drug interaction? Geubel AP; Nakad A; Rahier J; Dive C Liver; 1988 Dec; 8(6):350-3. PubMed ID: 3265170 [TBL] [Abstract][Full Text] [Related]
3. Cholestasis and liver cell damage due to hypersensitivity to erythromycin stearate--recurrence following therapy with erythromycin succinate. Horn S; Aglas F; Horina JH Wien Klin Wochenschr; 1999 Jan; 111(2):76-7. PubMed ID: 10081126 [TBL] [Abstract][Full Text] [Related]
7. [Acute hepatitis caused by erythromycin esters (propionate and ethylsuccinate)]. Paliard P; Stremsdoerfer N; Moindrot H Gastroenterol Clin Biol; 1983 Jan; 7(1):100-1. PubMed ID: 6601598 [No Abstract] [Full Text] [Related]
8. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate. Keeffe EB; Reis TC; Berland JE Dig Dis Sci; 1982 Aug; 27(8):701-4. PubMed ID: 6980110 [TBL] [Abstract][Full Text] [Related]
9. Modifications of the lymphocyte transformation test in a case of drug-induced cholestatic hepatitis. Victorino RM; Maria VA Diagn Immunol; 1985; 3(4):177-81. PubMed ID: 2935353 [TBL] [Abstract][Full Text] [Related]
20. Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature. Grieco A; Vecchio FM; Greco AV; Gasbarrini G Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):713-5. PubMed ID: 9744703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]